Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions
Shiying Shao, Qinqin Xu, Xuefeng Yu, et al.
Pharmacology & Therapeutics (2020) Vol. 209, pp. 107503-107503
Open Access | Times Cited: 174

Showing 1-25 of 174 citing articles:

The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
Li Yu, Ziding Zhang, Yang Li, et al.
iScience (2020) Vol. 23, Iss. 8, pp. 101400-101400
Open Access | Times Cited: 223
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
Li Yu, Ziding Zhang, Yang Li, et al.
iScience (2020) Vol. 23, Iss. 6, pp. 101160-101160
Open Access | Times Cited: 208
Adipokines: masterminds of metabolic inflammation
Herbert Tilg, Gianluca Ianiro, Antonio Gasbarrini, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 18
Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways
Nami Lee, Yu Jung Heo, Sung‐E Choi, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 100
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Inés Valencia, Concepción Peiró, Óscar Lorenzo, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 95
Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?
Niki Katsiki, Ele Ferrannini
Journal of Diabetes and its Complications (2020) Vol. 34, Iss. 12, pp. 107723-107723
Open Access | Times Cited: 78
Low-grade inflammation in type 2 diabetes: a cross-sectional study from a Danish diabetes outpatient clinic
Tina Okdahl, Anne‐Marie Wegeberg, Flemming Pociot, et al.
BMJ Open (2022) Vol. 12, Iss. 12, pp. e062188-e062188
Open Access | Times Cited: 47
Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease
Jie Huang, Xinxin Liu, Yingying Wei, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Acute kidney injury in diabetes mellitus: Epidemiology, diagnostic, and therapeutic concepts
Yuan Gui, Zachary Palanza, Haiyan Fu, et al.
The FASEB Journal (2023) Vol. 37, Iss. 4
Open Access | Times Cited: 24
Recent advances in the adjunctive management of diabetic foot ulcer: Focus on noninvasive technologies
Fen Wang, Xiaoling Zhang, Jing Zhang, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1501-1544
Closed Access | Times Cited: 8
The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
Tianli Zhang, Tong Xiang, Shijie Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 49
Impact of Sitagliptin on Non-diabetic Covid-19 Patients
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Current Molecular Pharmacology (2021) Vol. 15, Iss. 4, pp. 683-692
Closed Access | Times Cited: 45
Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis
Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 7, pp. 1379-1386
Open Access | Times Cited: 44
Emodin accelerates diabetic wound healing by promoting anti-inflammatory macrophage polarization
Chujun Chen, Zhenming Lin, Wenbin Liu, et al.
European Journal of Pharmacology (2022) Vol. 936, pp. 175329-175329
Closed Access | Times Cited: 32
Obesity and COVID-19: Mechanistic Insights From Adipose Tissue
Lili Yu, Xiaoying Zhang, Sarah Ye, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. 1799-1811
Open Access | Times Cited: 28
Association of Dipeptidylpeptidase 4 (CD26) With Chondrocyte Senescence and Radiographic Progression in Knee Osteoarthritis
Yu‐Hsiu Chen, Xin Zhang, Ching‐Heng Chou, et al.
Arthritis & Rheumatology (2023) Vol. 75, Iss. 7, pp. 1120-1131
Open Access | Times Cited: 19
Chemical and biological characterization of the DPP-IV inhibitory activity exerted by lupin (Lupinus angustifolius) peptides: From the bench to the bedside investigation
Iván Cruz-Chamorro, Guillermo Santos‐Sánchez, Carlotta Bollati, et al.
Food Chemistry (2023) Vol. 426, pp. 136458-136458
Open Access | Times Cited: 16
Neopterin and biopterin levels and tryptophan degradation in patients with diabetes
Sinem GÜRCÜ, Gözde Girgin, Göknur Yorulmaz, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 43
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations
André Scheen
Diabetes & Metabolism (2020) Vol. 47, Iss. 2, pp. 101213-101213
Open Access | Times Cited: 42
Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication
Yi Zhang, Liang Tang
Journal of Proteome Research (2020) Vol. 20, Iss. 1, pp. 49-59
Closed Access | Times Cited: 42
The role of Dipeptidyl Peptidase‐4 in cutaneous disease
Payal M. Patel, Virginia Jones, Khalaf Kridin, et al.
Experimental Dermatology (2020) Vol. 30, Iss. 3, pp. 304-318
Open Access | Times Cited: 40
DPP4 Activity, Hyperinsulinemia, and Atherosclerosis
Kaitlin M. Love, Zhenqi Liu
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 6, pp. 1553-1565
Open Access | Times Cited: 36
A Randomized Trial of Sitagliptin and Spironolactone With Combination Therapy in Hospitalized Adults With COVID-19
Farhad Abbasi, Reuben Adatorwovor, Mohammad Ali Davarpanah, et al.
Journal of the Endocrine Society (2022) Vol. 6, Iss. 4
Open Access | Times Cited: 23
Nonenzymatic function of DPP4 promotes diabetes-associated cognitive dysfunction through IGF-2R/PKA/SP1/ERp29/IP3R2 pathway-mediated impairment of Treg function and M1 microglia polarization
Ya Hui, Zhiqiang Xu, Jiaxiu Li, et al.
Metabolism (2022) Vol. 138, pp. 155340-155340
Closed Access | Times Cited: 23
Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer
Bei Zuo, Tao Li, Xiaoyun Liu, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 11, pp. 3188-3202
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top